Belite Bio is a clinical-stage pharmaceutical company that develops oral treatments for eye diseases and metabolic disorders. Their primary focus is a lead drug candidate currently undergoing late-stage clinical trials to prevent vision loss in patients with retinal conditions. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
